• This report updates the 2010 recommendations from the CDC Advisory Committee on Immunization Practices (ACIP) regarding prevention of Japanese encephalitis (JE) among U.S. travelers and laboratory workers (Fischer M, Lindsey N, Staples JE, Hills S. Japanese encephalitis vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP). (cdc.gov)
  • citation needed] Vaccines marketed by Valneva include Ixiaro, a vaccine against Japanese encephalitis (approved in Europe, America and Australia) and Dukoral, a vaccine against cholera (approved in Europe and Australia). (wikipedia.org)
  • Under this new one-year contract, the DoD will buy a minimum of $32 million worth of IXIARO® vaccines and has the possibility to purchase additional doses during the coming twelve months. (yahoo.com)
  • At our clinic, we offer various travel vaccines to safeguard our patients from illnesses commonly present in different regions around the world , including traveller's diarrhea, yellow fever, typhoid fever, hepatitis A & B, encephalitis, Japanese encephalitis, rabies, and meningitis. (travelhealthwindsor.com)
  • Valneva UK Limited is focused on the marketing and distribution in the United Kingdom of Valneva's vaccines IXIARO® Japanese encephalitis vaccine (inactivated adsorbed), DUKORAL® cholera vaccine (inactivated, oral), RABIPUR® rabies vaccine (inactivated, adsorbed) and PREHEVBRI® ▼ Hepatitis B vaccine (recombinant, adsorbed). (valneva.co.uk)
  • Are Japanese Encephalitis Vaccines Interchangeable? (contagionlive.com)
  • There are currently 15 Japanese Encephalitis vaccines in use worldwide. (contagionlive.com)
  • The investigators recommended further research comparing immune responses between JENVAC and other inactivated Japanese Encephalitis vaccines in endemic settings. (contagionlive.com)
  • Product sales nearly doubled to €32.1m driven by strongly recovering demand for the travel vaccines Ixiaro (Japanese encephalitis) and Dukoral (cholera, ETEC). (finanzresearch.ch)
  • Syncope can occur in association with administration of injectable vaccines, including IXIARO. (preventje.com)
  • The number of STIKO decisions were between 2 for the diphtheria/Haemophilus influenzae type B/hepatitis B/pertussis/poliomyelitis/tetanus combination vaccine, the MMR-V combination vaccine and the Japanese encephalitis and the meningococci (type B) vaccine and 7 for the influenza, pneumococcal and shingles vaccines. (covalue.de)
  • IXIARO is a vaccine indicated for active immunization for the prevention of disease caused by Japanese encephalitis virus (JEV). (drugs.com)
  • Ixiaro is indicated for active immunization against Japanese encephalitis in adults, adolescents, children and infants aged two months and older . (europa.eu)
  • IXIARO® JESPECT® is an inactivated, adsorbed Vero cell culture-derived preventive vaccine against the Japanese encephalitis virus. (precisionvaccinations.com)
  • Valneva manufactures Japanese Encephalitis Viral vaccine (IXIARO®/JESPECT®) at its cGMP facilities in Livingston, Scotland. (unog.ch)
  • IXIARO contains protamine sulfate, a compound known to cause hypersensitivity reactions in some individuals. (drugs.com)
  • Immunocompromised individuals may have a diminished response to Ixiaro. (empr.com)
  • 3 years of age: Primary immunization with IXIARO consists of two (2) 0.25 mL doses, administered 28 days apart. (drugs.com)
  • Some of its candidates have failed in clinical trials: VLA43, a therapeutic vaccine against Pseudomonas aeruginosa, V710, a therapeutic vaccine against Staphylococcus aureus (in collaboration with Merck), and IC41, therapeutic vaccine against hepatitis C. Valneva along with Dynavax Technologies developed a candidate inactivated whole virus vaccine against COVID-19, VLA2001 derived from its Ixiaro Japanese encephalitis vaccine, which is undergoing a Phase 1/2 trial in the United Kingdom. (wikipedia.org)
  • VLA2001 leverages Valneva's well-established platform for IXIARO ® , its vaccine approved for active immunization for the prevention of Japanese encephalitis. (outbreaknewstoday.com)
  • Japanese encephalitis virus (JEV) immunization in patients ≥2mos of age. (empr.com)
  • Individuals with a history of severe allergic reaction to another Japanese encephalitis vaccine may be referred to an allergist for evaluation if immunization with IXIARO might be considered. (preventje.com)
  • angetrieben durch die stark anziehende Nachfrage nach den Reiseimpfstoffen Ixiaro (Japanische Enzephalitis) und Dukoral (Cholera, ETEC). (finanzresearch.ch)
  • Inactivated Vero cell culture-derived JE vaccine (Ixiaro [JE-VC]) is the only JE vaccine that is licensed and available in the United States. (cdc.gov)
  • The shot uses Valneva's Vero-cell platform, which is used for the company's licensed Japanese encephalitis vaccine, IXIARO. (biopharma-reporter.com)
  • IXIARO is administered intramuscularly. (drugs.com)
  • In the United States, Japanese encephalitis mostly develops among travelers returning from endemic countries. (medscape.com)
  • The new study examined a single dose of JENVAC in comparison with IXIARO, the SA 14-14-2 vaccine, as well as interchangeability of a 2-dose regimen of either vaccine. (contagionlive.com)
  • Children enrolled were equally randomized to receive either JENVAC or IXIARO and were followed for 1 year after receiving a single dose of either vaccine. (contagionlive.com)
  • This needs to be done well before you travel - for maximum effectiveness the JE vaccine, known as Ixiaro, should be given in two doses four weeks apart, and the last dose should be given at least a week before you are exposed to Japanese encephalitis. (canadiantravelclinics.ca)
  • The Japanese encephalitis vaccine (Ixiaro) is recommended for those staying in rural parts of the country, and consists of two doses ideally given one month apart, so ensure that you have enough time if you need it. (bradtguides.com)
  • Ixiaro acts by inducing antibodies that neutralize live JEV. (empr.com)
  • Healthcare practitioners are encouraged to report use in pregnant women to the distributor, Valneva USA, Inc., at 844-349-4276 (8443-IXIARO). (empr.com)
  • Safety and effectiveness of Ixiaro have not been established in infants younger than 2 months of age. (empr.com)
  • Title : New clinical data for IXIARO® Japanese encephalitis vaccine, inactivated, adsorbed Personal Author(s) : Dubischar, Katrin Corporate Authors(s) : Valneva Conference Author(s) : United States. (cdc.gov)
  • There are no adequate and well-controlled studies of Ixiaro in pregnant women, and human data available from clinical trials and post-marketing experience with Ixiaro are insufficient to establish the presence or absence of drug-associated risk during pregnancy. (empr.com)
  • Consider the developmental and health benefits of breastfeeding along with the mother's clinical need for Ixiaro and any potential adverse effects on the breastfed child from Ixiaro or from the underlying maternal condition. (empr.com)
  • In a randomized, controlled, open-label clinical trial (Study 1) conducted in the Philippines, the immunogenicity of Ixiaro was evaluated in a subgroup of healthy children. (empr.com)
  • These highlights do not include all the information needed to use IXIARO safely and effectively. (drugs.com)
  • Most cases are mild, but the flu-like symptoms of Japanese encephalitis could spoil your trip or slow you down for a few days, and it has the potential to be more serious, too. (canadiantravelclinics.ca)
  • IXIARO is an inactivated cell-derived vaccine based on the same SA 14-14-2 strain of Japanese Encephalitis as CD.JEVAX. (contagionlive.com)
  • This recommendation followed approval by the FDA in May 2013 to extend use of the SA 14 -14-2 strain Japanese encephalitis vaccine (Ixiaro), the only vaccine against the disease available in the United States, to children aged 2 months to 16 years. (medscape.com)